Date Initiated by Firm | March 11, 2016 |
Create Date | September 09, 2016 |
Recall Status1 |
Terminated 3 on September 13, 2016 |
Recall Number | Z-2777-2016 |
Recall Event ID |
73689 |
Product Classification |
Device, dermal replacement - Product Code MDD
|
Product | Integra Meshed Dermal Regeneration Template 5 cmx 5 cm (2 in x 2in) Rx Only
Meshed Integra Dermal Regeneration Template, (Integra template) is a bilayer membrane system for skin replacement. The dermal replacement layer is made of a porous matrix of fibers of cross-linked bovine tendon collagen and glycosaminoglycan (chondroitin-6-sulfate) that is manufactured with a controlled porosity and defined degradation rate. The epidermal substitute layer is made of a thin polysiloxane (silicone) layer to control moisture loss from the wound. Integra template is indicated for the postexcisional treatment of life-threatening full-thickness or deep partial-thickness thermal injuries where sufficient autograft is not available at the time of excision or not desirable due to the physiological condition of the patient. Integra template is also indicated for the repair of scar contractures when other therapies have failed or when donor sites for repair are not sufficient or desirable due to the physiological condition of the patient
Manufactured by:
Integra LifeSciences Corporation
311 Enterprise Drive, Plainsboro, NJ 08536
877-444-1122 USA n 609-936-5400 outside USA
866-800-7742 fax |
Code Information |
Catalogue No. MIDRT 8101 Lot No. 105A00324750 |
Recalling Firm/ Manufacturer |
Integra LifeSciences Corporation 105 Morgan Ln Plainsboro NJ 08536-3339
|
For Additional Information Contact | Mr. David E. Gronostajski 609-275-2700 |
Manufacturer Reason for Recall | Integra's post QA release review of historical product release test results for Meshed IDRT products identified the Peel Strength test average result was incorrectly calculated for a single Lot (Lot 105A00324750). |
FDA Determined Cause 2 | Under Investigation by firm |
Action | Integra LifeSciences Inc. sent an urgent voluntary medical device recall letter/recall acknowledgement and return form dated March 11. 2016. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to review their inventory for the affected product and immediately stop using and remove from service. Customers were asked to complete the attached form and return by email or fax as indicated on the form. Customers with questions were advised to contact Customer Service at 1-888-601-0203.
For questions regarding this recall call 609-275-2700. |
Quantity in Commerce | 14 packages |
Distribution | Nationwide Distribution to PA |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|